...
首页> 外文期刊>Neuropsychobiology >Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.
【24h】

Genetic association analysis of functional polymorphisms in neuronal nitric oxide synthase 1 gene (NOS1) and mood disorders and fluvoxamine response in major depressive disorder in the Japanese population.

机译:神经元一氧化氮合酶1基因(NOS1)和情绪紊乱的遗传关联分析及日本人群重大抑郁紊乱中的情绪障碍和氟毒性紊乱。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIM: Nitric oxide has been reported to play a role in neural transmitter release and N-methyl-D-aspartate receptor activation, as well as to be related to oxidative stress. Abnormalities in both of these mechanisms are thought to be involved in the pathophysiology of mood disorders including major depressive disorder (MDD) and bipolar disorder (BP). In addition, several lines of evidence support an association between abnormalities in neuronal nitric oxide synthases (nNOS) and mood disorders. Therefore, we studied the association of nNOS gene (NOS1) and mood disorders and the efficacy of fluvoxamine treatment in Japanese MDD patients. MATERIALS AND METHODS: Using a single nucleotide polymorphism (SNP; rs41279104, also called ex1c), we conducted a genetic association analysis of case-control samples (325 MDD patients, 154 BP patients and 807 controls) in the Japanese population. In addition, we performed an association analysis between NOS1 and the efficacy of fluvoxamine treatment in 117 MDD patients. We defined a clinical response as a decrease of more than 50% in baseline SIGH-D (Structured Interview Guide for the Hamilton Rating Scale for Depression) score within 8 weeks, and clinical remission as an SIGH-D score of less than 7 at 8 weeks. RESULTS: We did not detect a significant association between NOS1 and MDD, BP or the fluvoxamine therapeutic response in MDD in allele/genotype-wise analysis. CONCLUSIONS: We did not detect an association between only one marker (rs41279104) in NOS1 and Japanese mood disorder patients and fluvoxamine response, but sample sizes were probably too small to allow a meaningful test. Moreover, because we did not perform an association analysis based on linkage disequilibrium and a mutation scan of NOS1, a replication of the study using a larger sample and based on linkage disequilibrium may be required for conclusive results.
机译:背景/目的:据报道,一氧化氮在神经发射器释放和N-甲基-D-天冬氨酸受体活化中起作用,以及与氧化应激相关的作用。认为这两种机制的异常都被认为参与情绪障碍的病理生理学,包括主要抑郁症(MDD)和双相障碍(BP)。此外,几种证据支持神经元一氧化氮合成酶(NNOS)和情绪障碍异常之间的关联。因此,我们研究了NNOS基因(NOS1)和情绪紊乱的关联以及氟毒素治疗在日本MDD患者中的疗效。材料和方法:使用单一核苷酸多态性(SNP; RS41279104,也称为EX1C),我们在日本人口中进行了案例对照样品(325名MDD患者,154名BP患者和807名患者)的遗传关联分析。此外,我们在117名MDD患者中进行了NOS1与氟苯胺治疗的疗效进行了关联分析。我们将临床反应定义为在8周内以基线SIGH-D(汉密尔顿评级规模的结构化面试指南)在8周内分解的临床反应,以及临床缓解,叹息小于8点小于7周。结果:在等位基因/基因型 - 明智分析中,我们没有检测到MDD中的NOS1和MDD,BP或Fluvoxamine治疗反应之间的显着关联。结论:我们没有检测到NOS1和日本情感障碍患者的一个标记(RS41279104)之间的关联和氟诺拉明患者,但样本尺寸可能太小而无法允许有意义的测试。此外,由于我们没有基于联系不平衡和NOS1的突变扫描进行关联分析,因此可以使用较大样品和基于联系不平衡的研究复制,可确凿的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号